Chief Complaint
Norma is a 54
year-old, former ICU nurse, referred from the Clinic for admission due to
symptoms of increasing dyspnea, peripheral edema and hypotension.
History of Present Illness
She is
well known to the cardiologists from previous evaluations. Norma has a history
of hospitalizations that average an admission every 5 months, the latest being
at the beginning of June 2003. This hospitalization lasted approximately 5
days with very little fluid removed using IV Lasix®, Natrecor®, and a Primacor®
drip.
Previous Medical History
On August 6,
2003, she presented at the Clinic in a similar manner to her admission in June.
Prior to this admission, Norma has been taking Lasix® 80 mg b.i.d., Aldactone®
25 mg q.d., K-Dur® 10 mEq b.i.d., Digitek® 0.125 mg q.d., Darvocet®, Zaroxolyn®,
Restoril® 30 mg q hs, Altace® 5 mg q.d., Coreg® 6.2 mg b.i.d., in addition to
attending the Infusion Clinic twice a week for Primacor® and the recently added,
Natrecor® infusions.
Norma has
a history of hypertension, diabetes mellitus, coronary artery disease,
status-post coronary artery bypass grafting in April 1994 with repeat bypass
grafting due to graft occlusion in March 2002. She has a history of
ventricular arrhythmia and is status-post automatic implantable cardioverter
defibrillator (AICD) implant. She was upgraded to a biventricular pacer
with AICD in June 2003.
Case Details
Her worsening
condition required her admission to Hospital and her treatment plan was unknown
at the time of her admission. She was showing signs of becoming refractory
to most medications. In April of 2003, the hospital began evaluating the
use of our system for fluid removal. When Norma was admitted,
it was clear that she would be a strong candidate for use of the device. A
venous catheter was placed for blood withdrawal and an existing peripheral IV
catheter was used for infusion.
After her
our unit treatments, Norma has been responding well to her oral
diuretics. In fact, her doses have been cut in half to what they were
prior to treatment. She is currently prescribed Lasix® 40 mg b.i.d.,
Aldactone® 12.5 mg q.d., K-Dur® 10 mEq b.i.d., Digitek® 0.125 mg q.d., Darvocet®,
Zaroxolyn®, Restoril® 30 mg q hs, Altace® 5 mg q.d., Coreg® 6.2 mg b.i.d.
Discussion
The nurses
reported that our system is quite simple to use. After seeing how
effectively the device operates, they are eager to use it to help more patients.
More than this, they are impressed by how stable the patient remains on the
device, the levels of monitoring it really requires, and the immediate
improvements to the patient’s fluid overloaded condition with a reduction of
symptoms. Norma would have to agree. As the treatments began, she
soon stated that her breathing had improved and she could now lean over, bend
her legs, and put her socks and slippers on. Upon admission, she was
unable to lift or bend her legs to get into the car without assistance.
Norma summed up her feelings in the following quote:
“As a
former ICU nurse, I have taken care of patients in the same condition that I am
now. I never dreamed I would be the patient. After one treatment, my
abdomen went way down, I was able to bend my legs to sit in a chair, and my
breathing became so much better. The difference in how I feel, in such a
short period of time, is remarkable.”
- Norma, August 8, 2003
Marion, OH